Fig. 1From: Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapyDistribution of baseline O-glycosylated HBsAg serum levels in the study cohort. The bar in each scatter plot represents the median value. Results for HBeAg-positive and -negative patients were compared using the Mann–Whitney U-test. HBeAg hepatitis B e antigen, HBsAg hepatitis B surface antigenBack to article page